Filing Details

Accession Number:
0001209191-14-064327
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-10-22 16:50:28
Reporting Period:
2014-10-21
Filing Date:
2014-10-22
Accepted Time:
2014-10-22 16:50:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1516479 Insys Therapeutics Inc. INSY Pharmaceutical Preparations (2834) 510327886
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1368078 L Michael Babich 444 South Ellis Street
Chandler AZ 85224
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-10-21 20,000 $3.54 189,795 No 4 M Direct
Common Stock Disposition 2014-10-21 20,000 $40.17 169,795 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2014-10-21 20,000 $0.00 20,000 $3.54
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
243,750 2022-12-26 No 4 D Direct
Footnotes
  1. Includes 4,233 shares acquired by the Reporting Person on June 10, 2014 pursuant to the Issuer's ESPP.
  2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  3. The weighted average sales price for the transaction reported was $40.1702, and the range of prices were between $40.00 to $40.45.
  4. The option vests in 36 equal monthly installments measured from the grant date of December 27, 2012 and will be fully vested and exercisable on December 27, 2015.